The Relationship Between Symptom Prevalence and Severity and Cancer Primary Site in 796 Patients With Advanced Cancer

Knowledge of differences in symptom experience between cancer sites may help better understand symptom pathophysiology. A total of 38 symptoms in 796 consecutive patients with advanced cancer were retrospectively analyzed. Symptom prevalence and severity were compared among the 12 primary site groups (PSGs) by the chi-square test. Pairwise comparisons determined which sites differed. Pain, fatigue, weakness, lack of energy, and anorexia had the highest overall prevalence but did not differ among PSGs. The 3 most common neuropsychological symptoms (insomnia, depression, and anxiety) also did not vary among PSGs. Nineteen (50%) symptoms varied significantly between PSGs, in prevalence (17), severity (14), or both (12). Nine of 17, 6 of 14, and 6 of 12 were gastrointestinal symptoms. Symptoms which varied by PSGs can be included in cancer site-specific symptom assessment instruments.

[1]  L. Lipsitz,et al.  Neural mechanisms of delirium: current hypotheses and evolving concepts. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  H. Thaler,et al.  Symptom prevalence, characteristics and distress in a cancer population , 1994, Quality of Life Research.

[3]  M. Wichers,et al.  Cytokines and major depression , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  E. Blanchard,et al.  Cancer-related pain--I. Prevalence in an outpatient setting as a function of stage of disease and type of cancer. , 1984, Journal of psychosomatic research.

[5]  S. Mercadante,et al.  Sleep disorders in advanced cancer patients: prevalence and factors associated , 2004, Supportive Care in Cancer.

[6]  H. Thaler,et al.  The Memorial Symptom Assessment Scale Short Form (MSAS‐SF) , 2000, Cancer.

[7]  G. Morrow,et al.  Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. , 2005, Journal of pain and symptom management.

[8]  A. Auvinen,et al.  Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. , 1996, Journal of pain and symptom management.

[9]  Mellar P. Davis,et al.  Early satiety in cancer patients: a common and important but underrecognized symptom , 2006, Supportive Care in Cancer.

[10]  D. Walsh,et al.  Common symptoms in advanced cancer. , 2000, Seminars in oncology.

[11]  C. Cleeland,et al.  Chinese version of the M. D. Anderson Symptom Inventory , 2004, Cancer.

[12]  C. Cleeland.  Cancer-related symptoms. , 2000, Seminars in radiation oncology.

[13]  D. Walsh,et al.  The Symptoms of Advanced Cancer: Identification of Clinical and Research Priorities by Assessment of Prevalence and Severity , 1995, Journal of palliative care.

[14]  J. Sloan,et al.  Dyspnea in cancer patients: prevalence and associated factors. , 2001, Journal of pain and symptom management.

[15]  N. Hiramanek.  Itch: a symptom of occult disease. , 2004, Australian family physician.

[16]  D. Walsh,et al.  The symptoms of advanced cancer. , 1995, Seminars in oncology.

[17]  C. Cleeland,et al.  The prevalence and severity of pain in cancer , 1982, Cancer.

[18]  Mellar P. Davis,et al.  Symptom severity and distress in advanced cancer , 2010, Palliative medicine.

[19]  S. Grond,et al.  Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. , 1994, Journal of pain and symptom management.

[20]  D. Walsh,et al.  The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients , 2000, Supportive Care in Cancer.

[21]  D. Walsh,et al.  Symptoms and prognosis in advanced cancer , 2002, Supportive Care in Cancer.

[22]  C. Jara,et al.  An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer. , 2005, Clinical nutrition.

[23]  R. Chlebowski,et al.  Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration , 1989, Cancer.

[24]  M. Opp.  Cytokines and sleep. , 2005, Sleep medicine reviews.

[25]  S. Fosså,et al.  The impact of demographic and disease-specific variables on pain in cancer patients. , 2003, Journal of pain and symptom management.

[26]  S. Ahmedzai.  Cough in cancer patients. , 2004, Pulmonary pharmacology & therapeutics.

[27]  P. Stone,et al.  A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  S. Braver,et al.  The measurement of clinical pain intensity: a comparison of six methods , 1986, Pain.

[29]  A. Dunn,et al.  Cytokines as mediators of depression: What can we learn from animal studies? , 2005, Neuroscience & Biobehavioral Reviews.

[30]  T. Chiu,et al.  Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan , 2000, Supportive Care in Cancer.